Variable | Age (year) | Sex | Smoking | Family history of cancer | |||
---|---|---|---|---|---|---|---|
Mean (SD) | Male (%) | Female (%) | Yes (%) | No (%) | Positive (%) | Negative (%) | |
Tumor Grade | |||||||
 Low grade | 62.71 (10.45) | 46 (54.10) | 13 (61.90) | 44 (54.3) | 15 (60) | 21 (44.70) | 38 (64.40) |
 High grade | 63.32 (10.13) | 39 (45.90) | 8 (38.10) | 37 (45.7) | 10 (40) | 26 (55.30) | 21 (35.60) |
P-Value | 0.764 a | 0.520 c | 0.617 c | 0.042 c | |||
Tumor Stage | |||||||
 Ta | 62.02 (9.99) | 40 (47.10) | 10 (47.60) | 38 (46.90) | 12 (48.00) | 17 (36.20) | 33 (55.90) |
 T1 | 67.92 (12.57) | 10 (11.80) | 3 (14.30) | 10 (12.30) | 3 (12.00) | 5 (10.60) | 8 (13.60) |
 T2 | 65.15 (8.39) | 26 (30.60) | 7 (33.30) | 24 (29.60) | 9 (36.00) | 21 (44.70) | 12 (20.30) |
 T3-T4 | 54.20 (9.00) | 9 (10.60) | 1 (4.80) | 9 (11.10) | 1 (4.00) | 4 (8.50) | 6 (10.20) |
P-Value | 0.005 b | 0.865 c | 0.734 c | 0.060 c | |||
Muscle Invasion | |||||||
 Positive | 62.60 (9.64) | 35 (41.20) | 8 (38.10) | 33 (40.70) | 10 (40) | 25 (53.20) | 18 (30.50) |
 Negative | 63.24 (10.73) | 50 (58.80) | 13 (61.90) | 48 (59.30) | 15 (60) | 22 (46.80) | 41 (69.50) |
P-Value | 0.757 a | 0.797 c | 0.947 c | 0.018 c | |||
Recurrence after 18 months | |||||||
 Positive | 60.92 (10.63) | 49 (57.60) | 12 (57.10) | 49 (60.50) | 12 (48.00) | 36 (76.6) | 25 (42.40) |
 Negative | 65.78 (9.13) | 36 (42.40) | 8 (42.90) | 32 (39.50) | 13 (52.00) | 11 (23.4) | 34 (57.60) |
P-Value | 0.015 a | 0.976 c | 0.296 c | < 0.001 c |